312 related articles for article (PubMed ID: 9305659)
1. Natural history of hepatitis C.
Seeff LB
Hepatology; 1997 Sep; 26(3 Suppl 1):21S-28S. PubMed ID: 9305659
[TBL] [Abstract][Full Text] [Related]
2. Long-term mortality and morbidity of transfusion-associated non-A, non-B, and type C hepatitis: A National Heart, Lung, and Blood Institute collaborative study.
Seeff LB; Hollinger FB; Alter HJ; Wright EC; Cain CM; Buskell ZJ; Ishak KG; Iber FL; Toro D; Samanta A; Koretz RL; Perrillo RP; Goodman ZD; Knodell RG; Gitnick G; Morgan TR; Schiff ER; Lasky S; Stevens C; Vlahcevic RZ; Weinshel E; Tanwandee T; Lin HJ; Barbosa L
Hepatology; 2001 Feb; 33(2):455-63. PubMed ID: 11172349
[TBL] [Abstract][Full Text] [Related]
3. Natural history of hepatitis C virus infection: from chronic hepatitis to cirrhosis, to hepatocellular carcinoma.
Leone N; Rizzetto M
Minerva Gastroenterol Dietol; 2005 Mar; 51(1):31-46. PubMed ID: 15756144
[TBL] [Abstract][Full Text] [Related]
4. Advances in the treatment of hepatitis C.
Lawrence SP
Adv Intern Med; 2000; 45():65-105. PubMed ID: 10635046
[TBL] [Abstract][Full Text] [Related]
5. [Clinical picture and evolution of hepatitis C].
Marcellin P; Erlinger S
Bull Acad Natl Med; 1996; 180(6):1267-76; discussion 1276-8. PubMed ID: 8991608
[TBL] [Abstract][Full Text] [Related]
6. Late liver-related mortality from complications of transfusion-acquired hepatitis C.
Kamitsukasa H; Harada H; Tanaka H; Yagura M; Tokita H; Ohbayashi A
Hepatology; 2005 Apr; 41(4):819-25. PubMed ID: 15793849
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis C and hepatocellular carcinoma.
Di Bisceglie AM
Hepatology; 1997 Sep; 26(3 Suppl 1):34S-38S. PubMed ID: 9305661
[TBL] [Abstract][Full Text] [Related]
8. Assessment of long-term outcomes of community-acquired hepatitis C infection in a cohort with sera stored from 1971 to 1975.
Rodger AJ; Roberts S; Lanigan A; Bowden S; Brown T; Crofts N
Hepatology; 2000 Sep; 32(3):582-7. PubMed ID: 10960453
[TBL] [Abstract][Full Text] [Related]
9. [Treatment of recurrent HCV infection after liver transplantation].
Ostojić R
Acta Med Croatica; 2005; 59(5):443-6. PubMed ID: 16381241
[TBL] [Abstract][Full Text] [Related]
10. Clinical outcome of hepatitis C as a function of mode of transmission.
Gordon SC; Bayati N; Silverman AL
Hepatology; 1998 Aug; 28(2):562-7. PubMed ID: 9696025
[TBL] [Abstract][Full Text] [Related]
11. Long-term morbidity and mortality risk in Japanese insurance applicants with chronic hepatitis C virus infection.
Pokorski RJ
J Insur Med; 2001; 33(1):12-36. PubMed ID: 11317876
[TBL] [Abstract][Full Text] [Related]
12. Strategies for assessing the long-term consequences of Hepatitis C virus infection.
Seeff LB
Minerva Gastroenterol Dietol; 2000 Dec; 46(4):207-16. PubMed ID: 16501439
[TBL] [Abstract][Full Text] [Related]
13. The natural history of hepatitis C: clinical experiences.
Müller R
J Hepatol; 1996; 24(2 Suppl):52-4. PubMed ID: 8836889
[TBL] [Abstract][Full Text] [Related]
14. Natural history of hepatitis C and the impact of anti-viral therapy.
Boyer N; Marcellin P
Forum (Genova); 2000; 10(1):4-18. PubMed ID: 10717254
[TBL] [Abstract][Full Text] [Related]
15. The natural history of childhood-acquired hepatitis C infection in patients with inherited bleeding disorders.
Posthouwer D; Fischer K; van Erpecum KJ; Mauser-Bunschoten EP
Transfusion; 2006 Aug; 46(8):1360-6. PubMed ID: 16934072
[TBL] [Abstract][Full Text] [Related]
16. Serum insulin-like growth factor I evaluation as a useful tool for predicting the risk of developing hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis: a prospective study.
Mazziotti G; Sorvillo F; Morisco F; Carbone A; Rotondi M; Stornaiuolo G; Precone DF; Cioffi M; Gaeta GB; Caporaso N; Carella C
Cancer; 2002 Dec; 95(12):2539-45. PubMed ID: 12467068
[TBL] [Abstract][Full Text] [Related]
17. Clinical outcomes after transfusion-associated hepatitis C.
Tong MJ; el-Farra NS; Reikes AR; Co RL
N Engl J Med; 1995 Jun; 332(22):1463-6. PubMed ID: 7739682
[TBL] [Abstract][Full Text] [Related]
18. Long-term outcome of vertically acquired and post-transfusion hepatitis C infection in children.
Rerksuppaphol S; Hardikar W; Dore GJ
J Gastroenterol Hepatol; 2004 Dec; 19(12):1357-62. PubMed ID: 15610308
[TBL] [Abstract][Full Text] [Related]
19. Fibrosing cholestatic hepatitis in renal transplant recipients with hepatitis C virus infection.
Delladetsima JK; Boletis JN; Makris F; Psichogiou M; Kostakis A; Hatzakis A
Liver Transpl Surg; 1999 Jul; 5(4):294-300. PubMed ID: 10388502
[TBL] [Abstract][Full Text] [Related]
20. [Nine-year follow-up of hepatitis C virus infection in a rural area of Hebei province, China].
Fan WM; Zhu WF; Zhang SY; Wang QX; Yin LM; Wan H; Gao Y; Tian XL; Yu M; Jin J; Xu XY; Wei L; Zhuang H
Zhonghua Yi Xue Za Zhi; 2004 Mar; 84(5):392-6. PubMed ID: 15061992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]